US EditionDr Boreham's Crucible: The Aussie drug company giving thanks for US health sector mayhem
Summary by Stockhead
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Dr Boreham's Crucible: The Aussie drug company giving thanks for US health sector mayhem
Veteran drug contract manufacturer IDT Australia (ASX:IDT) can thank Donald Trump and Robert F Kennedy Junior’s shambolic approach to reforming US healthcare that shuns usual scientific rigour and has crimped medical research funding. Why? The mayhem has prompted growing interest in carrying out drug trials in Australia. “We are seeing more US companies wanting to manufacture their product in Australia and wanting to do their first-in-human tria…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
